(24/7 MARKET NEWS) – VBL Therapeutics (NASDAQ: VBLT) and Notable Labs, Inc. (“Notable”) announced, this morning, that they entered into a definitive merger agreement. The combined company is expected to operate under the name Notable Labs, Ltd. with its shares listed on the Nasdaq Capital Market under the ticker symbol ‘NTBL’ and will focus on the advancement of Notable’s proprietary Predictive Precision Medicines Platform and therapeutic pipeline focused on cancer patients with high unmet medical needs. Immediately after the merger, Notable stockholders are expected to own approximately 76% and VBL Therapeutics shareholders are expected to own approximately 24% of the combined company.
VBL Therapeutics is at $0.22, 9 cents higher (71.34%), on trading volume of 15 million premarket shares.
Its 52-week trading range is $0.1009 to $2.20. Its next key inflection points are $0.24 and this morning’s premarket high of $0.258. it has a gap from when it dropped from around $2 to 50-cents.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.